Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
18 Cards in this Set
- Front
- Back
|
Measles vaccine |
Live attenuated /freeze dried product (edmonstron Zagreb strain) (Subcutaneous -0.5ml) Administered at 9month, 15-18 months |
|
|
Influenza treatment |
1.Oseltamivir 75mg bd for 5 days (treatment) 2.For 10 days (chemoprophylaxis) 3. Isolation for 7 days |
|
|
Suspect of influenza |
A person with acute febrile respiratory illness with onset ° within 7 days of close contact with case ° within 7 days of travel to area with cases ° reside in community with cases |
|
|
Probable influenza |
A person with acute febrile respiratory illness °positive for influenza a but unsubtypable for H1 or h3 °positive for influenza a and meets criteria for a suspected case ° patient died of an unexplained acute illness who is considered epidemiologically linked to a probable or confirmed case |
|
|
Influenza vaccine |
a) inactivated influenza vaccine - paediatric dose (0.25ml) in thigh - 2 dose Adult dose (0.5ml) in deltoid -single dose b) live attenuated influenza vaccine (Single dose via nasal spray) |
|
|
Pentavalent vaccine |
For diphtheria tetanus pertussis influenza hep b Schedule:- 6,10,14 weeks Dose and site :- 0.5ml on anterolateral thigh Freeze sensitive vaccine |
|
|
Cholera prophylaxis |
Doxycycline bd 300mg in adults 125mg bd in children for 3 days |
|
|
Vaccines of cholera |
Dukoral :- for 01 type Sanechol- for 01 n 0139 type (50% effective) |
|
|
Japanese encephalitis |
Caused by flavivirus Mosquito :- culex tritaeniorhyncus, vishnui Man- accidental host (dead end) Reservoir - ardeid bird Cycle - ardeid bird <--> mosquito <--> pig (amplifying host) Vaccination: killed (Nakayama strain) Inactivated (SA 14-14) Schedule - 9th month , 16-24 month <15yrs Min gap - 3 months Dose - subcutaneous <3 - 0.5 ml n >3 yrs - 1ml Dilient-phosphate buffer Travellers ( >3weeks) - 0 ,7,28 days |
|
|
Tetanus vaccine |
Prophylaxis - 6, 10, 14 weeks (pentavalent) 16-24 months + 5-6 yrs ( DPT ) 10yrs + 16 yrs - TD Postexposure- 2p doses (gap-1month) later booster dose Passive immunisation- human tetanus immunoglobulin (250IU) |
|
|
Emerging disease |
Ebola , Zika and nipah |
|
|
Ebola |
Filoviridae family Reservoir - bat, wild animals Mode of transmission - body secretions, seminal secretions MC cause of death- renal failure |
|
|
DPT |
Dose: 0.5ml in anterolateral thigh 3 doses in infants - 6,10, 14 weeks 11/2 year - booster ,5year - booster a) if >5yrs n no immunisation- 2 doses of DT given , booster : after 6months or 1 yr b) if >12 yrs (in adults) : dt given |
|
|
Leprosy treatment |
Multibacillary- 600mg rifampicin once a month under supervision 100mg dapsone daily 300mg clofazamine once a month , 50 mg daily |
|
|
Vivax malaria treatment |
Chloroquine 10mg on 1st n 2nd day, 5mg on 3rd day Primaquine for 15 days 0.25mg/kg |
|
|
Falciparum Malaria in ne treatment |
Artemether + lumefantrine for 3 days Primaquine 0.75mg/kg on 2nd day |
|
|
Falciparum Malaria in other states |
Artesunate + sulfadoxine + pyrimethamine Primaquine 0.75mg/kg on second day |
|
|
Filariasis treatment |
Albendazole 400mg + ivermectin (150-200mcg/kg) or diethylcarbamazine citrate (DEC) (6mg/kg) |
